Bright Minds Biosciences

Vancouver, Canada

Bright Minds Biosciences is a biotech company that engages in the development of serotonergic therapeutics to treat mental health disorders.

$175.1M raised

Jan 2026

Post-IPO Equity

Biotechnology Health Care Medical Mental Health

Top Investors

PsyMed Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Bright Minds Biosciences

How much funding has Bright Minds Biosciences raised?

Bright Minds Biosciences has raised $175.1M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2026.

Who are Bright Minds Biosciences's investors?

Bright Minds Biosciences's investors include PsyMed Ventures.

Where is Bright Minds Biosciences headquartered?

Bright Minds Biosciences is headquartered in Vancouver, Canada.

What does Bright Minds Biosciences do?

Bright Minds Biosciences is a biotech company that engages in the development of serotonergic therapeutics to treat mental health disorders.

What stage is Bright Minds Biosciences at?

Bright Minds Biosciences is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 7, 2026.

MLA

"Bright Minds Biosciences — Funding & Investors." VCBacked, January 7, 2026, https://www.vcbacked.co/company/bright-minds-biosciences. Accessed July 3, 2026.

APA

VCBacked. (2026). Bright Minds Biosciences — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/bright-minds-biosciences

Wikipedia (cite web)

{{cite web |title=Bright Minds Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/bright-minds-biosciences |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 7, 2026.